![Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial | Dermatology and Therapy Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial | Dermatology and Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs13555-020-00387-7/MediaObjects/13555_2020_387_Fig5_HTML.jpg)
Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial | Dermatology and Therapy
![Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: Follow up of a pilot study and promising future directions - Tu - 2014 - Australasian Journal of Dermatology - Wiley Online Library Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: Follow up of a pilot study and promising future directions - Tu - 2014 - Australasian Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c4247e05-e9a3-46c5-a9b5-2484be098f55/ajd12125-fig-0004-m.jpg)
Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: Follow up of a pilot study and promising future directions - Tu - 2014 - Australasian Journal of Dermatology - Wiley Online Library
![Topical sirolimus for treatment of a venolymphatic malformation in an adolescent girl - Cardis - 2018 - Pediatric Dermatology - Wiley Online Library Topical sirolimus for treatment of a venolymphatic malformation in an adolescent girl - Cardis - 2018 - Pediatric Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/aa17520d-6052-4b4b-a2d2-f0128bfa0dc2/pde13622-fig-0001-m.jpg)
Topical sirolimus for treatment of a venolymphatic malformation in an adolescent girl - Cardis - 2018 - Pediatric Dermatology - Wiley Online Library
![Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: Follow up of a pilot study and promising future directions - Tu - 2014 - Australasian Journal of Dermatology - Wiley Online Library Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: Follow up of a pilot study and promising future directions - Tu - 2014 - Australasian Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/cb2e116b-de1f-4bcf-ab2a-192c61f16b14/ajd12125-fig-0006-m.jpg)
Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: Follow up of a pilot study and promising future directions - Tu - 2014 - Australasian Journal of Dermatology - Wiley Online Library
![Preparation of Spray‐dried Emulsion of Sirolimus for Enhanced Oral Bioavailability - Goo - 2018 - Bulletin of the Korean Chemical Society - Wiley Online Library Preparation of Spray‐dried Emulsion of Sirolimus for Enhanced Oral Bioavailability - Goo - 2018 - Bulletin of the Korean Chemical Society - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b0722578-4ec8-4ec3-bcc5-db2716f0986e/bkcs11560-toc-0001-m.jpg)
Preparation of Spray‐dried Emulsion of Sirolimus for Enhanced Oral Bioavailability - Goo - 2018 - Bulletin of the Korean Chemical Society - Wiley Online Library
![Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial | Trials | Full Text Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial | Trials | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13063-019-3767-8/MediaObjects/13063_2019_3767_Fig1_HTML.png)
Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial | Trials | Full Text
![Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial | Dermatology and Therapy Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial | Dermatology and Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-020-00387-7/MediaObjects/13555_2020_387_Fig6_HTML.png)
Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial | Dermatology and Therapy
Allure Medical - 2 months of Sirolimus cream. Sirolimus (rapamycin) clinically halts or reverses the age of the skin. We have seen decreased pores, less fine lines, better color, more smoothness. All
![Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: Follow up of a pilot study and promising future directions - Tu - 2014 - Australasian Journal of Dermatology - Wiley Online Library Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: Follow up of a pilot study and promising future directions - Tu - 2014 - Australasian Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9290d399-0393-4dfd-88a0-dcd7545a7749/ajd12125-fig-0001-m.jpg)
Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: Follow up of a pilot study and promising future directions - Tu - 2014 - Australasian Journal of Dermatology - Wiley Online Library
![Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease | tctmd.com Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease | tctmd.com](https://d14d5nk8lue86f.cloudfront.net/s3fs-public/2023-05/Concept%20Medical%20received%20IDE%20approval.jpg)
Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease | tctmd.com
![Topical sirolimus for the treatment of angiofibromas in tuberous sclerosis - Indian Journal of Dermatology, Venereology and Leprology Topical sirolimus for the treatment of angiofibromas in tuberous sclerosis - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2017/83/1/Images/ijdvl_2017_83_1_27_190844_f4.jpg)
Topical sirolimus for the treatment of angiofibromas in tuberous sclerosis - Indian Journal of Dermatology, Venereology and Leprology
![Molecules | Free Full-Text | Enhanced Supersaturation and Oral Absorption of Sirolimus Using an Amorphous Solid Dispersion Based on Eudragit® E Molecules | Free Full-Text | Enhanced Supersaturation and Oral Absorption of Sirolimus Using an Amorphous Solid Dispersion Based on Eudragit® E](https://www.mdpi.com/molecules/molecules-20-09496/article_deploy/html/images/molecules-20-09496-g001.png)
Molecules | Free Full-Text | Enhanced Supersaturation and Oral Absorption of Sirolimus Using an Amorphous Solid Dispersion Based on Eudragit® E
![Topical sirolimus for the treatment of angiofibromas in tuberous sclerosis - Indian Journal of Dermatology, Venereology and Leprology Topical sirolimus for the treatment of angiofibromas in tuberous sclerosis - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2017/83/1/Images/ijdvl_2017_83_1_27_190844_f1.jpg)
Topical sirolimus for the treatment of angiofibromas in tuberous sclerosis - Indian Journal of Dermatology, Venereology and Leprology
![Blocking mTOR Signalling with Rapamycin Ameliorates Imiquimod-induced Psoriasis in Mice | HTML | Acta Dermato-Venereologica Blocking mTOR Signalling with Rapamycin Ameliorates Imiquimod-induced Psoriasis in Mice | HTML | Acta Dermato-Venereologica](https://www.medicaljournals.se/acta/html-editor/html-img/5002/5002_6714.png)
Blocking mTOR Signalling with Rapamycin Ameliorates Imiquimod-induced Psoriasis in Mice | HTML | Acta Dermato-Venereologica
![HYFTOR™ (sirolimus topical gel) 0.2%, the first FDA-approved topical treatment for facial angiofibroma associated with tuberous sclerosis, is now available in the US HYFTOR™ (sirolimus topical gel) 0.2%, the first FDA-approved topical treatment for facial angiofibroma associated with tuberous sclerosis, is now available in the US](https://mma.prnewswire.com/media/1538832/MicrosoftTeams_image_Logo.jpg)
HYFTOR™ (sirolimus topical gel) 0.2%, the first FDA-approved topical treatment for facial angiofibroma associated with tuberous sclerosis, is now available in the US
![Sirolimus-D3 solution 100 μg/mL in acetonitrile, certified reference material, ampule of 1 mL | Sigma-Aldrich Sirolimus-D3 solution 100 μg/mL in acetonitrile, certified reference material, ampule of 1 mL | Sigma-Aldrich](https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/structures/404/834/65f607d6-4ad2-497c-8ff9-6e87c6010750/640/65f607d6-4ad2-497c-8ff9-6e87c6010750.png)